ICON PLC (ICLR) Fundamental Analysis & Valuation

NASDAQ:ICLR • IE0005711209

Current stock price

110.66 USD
+5.56 (+5.29%)
At close:
110.2 USD
-0.46 (-0.42%)
After Hours:

This ICLR fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

6

1. ICLR Profitability Analysis

1.1 Basic Checks

  • In the past year ICLR was profitable.
  • In the past year ICLR had a positive cash flow from operations.
  • In the past 5 years ICLR has always been profitable.
  • Each year in the past 5 years ICLR had a positive operating cash flow.
ICLR Yearly Net Income VS EBIT VS OCF VS FCFICLR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

1.2 Ratios

  • The Return On Assets of ICLR (3.63%) is better than 76.79% of its industry peers.
  • With a decent Return On Equity value of 6.42%, ICLR is doing good in the industry, outperforming 76.79% of the companies in the same industry.
  • ICLR has a better Return On Invested Capital (6.74%) than 78.57% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for ICLR is significantly below the industry average of 11.80%.
  • The last Return On Invested Capital (6.74%) for ICLR is above the 3 year average (5.80%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 3.63%
ROE 6.42%
ROIC 6.74%
ROA(3y)3.74%
ROA(5y)4.36%
ROE(3y)6.96%
ROE(5y)8.15%
ROIC(3y)5.8%
ROIC(5y)6.92%
ICLR Yearly ROA, ROE, ROICICLR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20 25

1.3 Margins

  • ICLR has a better Profit Margin (7.40%) than 75.00% of its industry peers.
  • In the last couple of years the Profit Margin of ICLR has declined.
  • The Operating Margin of ICLR (13.99%) is better than 75.00% of its industry peers.
  • In the last couple of years the Operating Margin of ICLR has remained more or less at the same level.
  • With a Gross Margin value of 28.15%, ICLR is not doing good in the industry: 76.79% of the companies in the same industry are doing better.
  • In the last couple of years the Gross Margin of ICLR has remained more or less at the same level.
Industry RankSector Rank
OM 13.99%
PM (TTM) 7.4%
GM 28.15%
OM growth 3Y9.91%
OM growth 5Y-0.95%
PM growth 3Y50.65%
PM growth 5Y-6.44%
GM growth 3Y2.3%
GM growth 5Y-0.09%
ICLR Yearly Profit, Operating, Gross MarginsICLR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. ICLR Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so ICLR is destroying value.
  • ICLR has less shares outstanding than it did 1 year ago.
  • Compared to 5 years ago, ICLR has more shares outstanding
  • The debt/assets ratio for ICLR has been reduced compared to a year ago.
ICLR Yearly Shares OutstandingICLR Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
ICLR Yearly Total Debt VS Total AssetsICLR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

2.2 Solvency

  • Based on the Altman-Z score of 1.60, we must say that ICLR is in the distress zone and has some risk of bankruptcy.
  • ICLR's Altman-Z score of 1.60 is in line compared to the rest of the industry. ICLR outperforms 50.00% of its industry peers.
  • ICLR has a debt to FCF ratio of 3.53. This is a good value and a sign of high solvency as ICLR would need 3.53 years to pay back of all of its debts.
  • The Debt to FCF ratio of ICLR (3.53) is better than 78.57% of its industry peers.
  • A Debt/Equity ratio of 0.31 indicates that ICLR is not too dependend on debt financing.
  • ICLR has a Debt to Equity ratio (0.31) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity 0.31
Debt/FCF 3.53
Altman-Z 1.6
ROIC/WACC0.8
WACC8.4%
ICLR Yearly LT Debt VS Equity VS FCFICLR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B

2.3 Liquidity

  • A Current Ratio of 1.06 indicates that ICLR should not have too much problems paying its short term obligations.
  • Looking at the Current ratio, with a value of 1.06, ICLR is doing worse than 87.50% of the companies in the same industry.
  • A Quick Ratio of 1.06 indicates that ICLR should not have too much problems paying its short term obligations.
  • The Quick ratio of ICLR (1.06) is worse than 80.36% of its industry peers.
Industry RankSector Rank
Current Ratio 1.06
Quick Ratio 1.06
ICLR Yearly Current Assets VS Current LiabilitesICLR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. ICLR Growth Analysis

3.1 Past

  • ICLR shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -5.99%.
  • The Earnings Per Share has been growing by 15.23% on average over the past years. This is quite good.
  • Looking at the last year, ICLR shows a decrease in Revenue. The Revenue has decreased by -2.46% in the last year.
  • ICLR shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 24.17% yearly.
EPS 1Y (TTM)-5.99%
EPS 3Y13.76%
EPS 5Y15.23%
EPS Q2Q%-1.19%
Revenue 1Y (TTM)-2.46%
Revenue growth 3Y14.75%
Revenue growth 5Y24.17%
Sales Q2Q%0.63%

3.2 Future

  • Based on estimates for the next years, ICLR will show a small growth in Earnings Per Share. The EPS will grow by 2.14% on average per year.
  • Based on estimates for the next years, ICLR will show a small growth in Revenue. The Revenue will grow by 1.48% on average per year.
EPS Next Y-5.37%
EPS Next 2Y-4.18%
EPS Next 3Y0.09%
EPS Next 5Y2.14%
Revenue Next Year-2.67%
Revenue Next 2Y-1.68%
Revenue Next 3Y0.21%
Revenue Next 5Y1.48%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
ICLR Yearly Revenue VS EstimatesICLR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 2B 4B 6B 8B 10B
ICLR Yearly EPS VS EstimatesICLR Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 10 20 30

More info and screens

Find the best growth stocksShow best growing peers

7

4. ICLR Valuation Analysis

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 8.39, the valuation of ICLR can be described as very reasonable.
  • 98.21% of the companies in the same industry are more expensive than ICLR, based on the Price/Earnings ratio.
  • When comparing the Price/Earnings ratio of ICLR to the average of the S&P500 Index (25.35), we can say ICLR is valued rather cheaply.
  • With a Price/Forward Earnings ratio of 8.61, the valuation of ICLR can be described as very reasonable.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of ICLR indicates a rather cheap valuation: ICLR is cheaper than 98.21% of the companies listed in the same industry.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 22.61, ICLR is valued rather cheaply.
Industry RankSector Rank
PE 8.39
Fwd PE 8.61
ICLR Price Earnings VS Forward Price EarningsICLR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • ICLR's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. ICLR is cheaper than 98.21% of the companies in the same industry.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of ICLR indicates a rather cheap valuation: ICLR is cheaper than 100.00% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 8.76
EV/EBITDA 7.2
ICLR Per share dataICLR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 50 100

4.3 Compensation for Growth

  • ICLR has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)0.55
EPS Next 2Y-4.18%
EPS Next 3Y0.09%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. ICLR Dividend Analysis

5.1 Amount

  • ICLR does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

ICLR Fundamentals: All Metrics, Ratios and Statistics

ICON PLC

NASDAQ:ICLR (3/31/2026, 8:00:01 PM)

After market: 110.2 -0.46 (-0.42%)

110.66

+5.56 (+5.29%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)10-22
Earnings (Next)04-30
Inst Owners108.2%
Inst Owner Change4.34%
Ins Owners0.66%
Ins Owner Change0%
Market Cap8.45B
Revenue(TTM)8.10B
Net Income(TTM)599.48M
Analysts74.17
Price Target150.64 (36.13%)
Short Float %2.68%
Short Ratio1.01
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-0.77%
Min EPS beat(2)-1.21%
Max EPS beat(2)-0.34%
EPS beat(4)1
Avg EPS beat(4)-0.63%
Min EPS beat(4)-1.21%
Max EPS beat(4)0.23%
EPS beat(8)1
Avg EPS beat(8)-2.34%
EPS beat(12)2
Avg EPS beat(12)-1.79%
EPS beat(16)5
Avg EPS beat(16)-1.4%
Revenue beat(2)1
Avg Revenue beat(2)0.4%
Min Revenue beat(2)-0.23%
Max Revenue beat(2)1.03%
Revenue beat(4)1
Avg Revenue beat(4)-0.84%
Min Revenue beat(4)-2.61%
Max Revenue beat(4)1.03%
Revenue beat(8)1
Avg Revenue beat(8)-2.24%
Revenue beat(12)1
Avg Revenue beat(12)-2.14%
Revenue beat(16)1
Avg Revenue beat(16)-2.06%
PT rev (1m)-5.56%
PT rev (3m)-28.15%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-2.2%
EPS NY rev (1m)-0.7%
EPS NY rev (3m)-0.71%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.58%
Revenue NY rev (1m)-0.17%
Revenue NY rev (3m)-0.23%
Valuation
Industry RankSector Rank
PE 8.39
Fwd PE 8.61
P/S 1.04
P/FCF 8.76
P/OCF 7.41
P/B 0.91
P/tB N/A
EV/EBITDA 7.2
EPS(TTM)13.19
EY11.92%
EPS(NY)12.85
Fwd EY11.62%
FCF(TTM)12.63
FCFY11.41%
OCF(TTM)14.93
OCFY13.5%
SpS106.11
BVpS122.25
TBVpS-38.98
PEG (NY)N/A
PEG (5Y)0.55
Graham Number190.47
Profitability
Industry RankSector Rank
ROA 3.63%
ROE 6.42%
ROCE 8.53%
ROIC 6.74%
ROICexc 6.98%
ROICexgc 176.34%
OM 13.99%
PM (TTM) 7.4%
GM 28.15%
FCFM 11.9%
ROA(3y)3.74%
ROA(5y)4.36%
ROE(3y)6.96%
ROE(5y)8.15%
ROIC(3y)5.8%
ROIC(5y)6.92%
ROICexc(3y)5.97%
ROICexc(5y)8.67%
ROICexgc(3y)88.82%
ROICexgc(5y)90.84%
ROCE(3y)7.34%
ROCE(5y)8.76%
ROICexgc growth 3Y-4.45%
ROICexgc growth 5Y-5.01%
ROICexc growth 3Y27.99%
ROICexc growth 5Y-24.17%
OM growth 3Y9.91%
OM growth 5Y-0.95%
PM growth 3Y50.65%
PM growth 5Y-6.44%
GM growth 3Y2.3%
GM growth 5Y-0.09%
F-Score6
Asset Turnover0.49
Health
Industry RankSector Rank
Debt/Equity 0.31
Debt/FCF 3.53
Debt/EBITDA 1.89
Cap/Depr 45.31%
Cap/Sales 2.17%
Interest Coverage 250
Cash Conversion 74.92%
Profit Quality 160.84%
Current Ratio 1.06
Quick Ratio 1.06
Altman-Z 1.6
F-Score6
WACC8.4%
ROIC/WACC0.8
Cap/Depr(3y)27.79%
Cap/Depr(5y)38.09%
Cap/Sales(3y)1.87%
Cap/Sales(5y)1.83%
Profit Quality(3y)130.43%
Profit Quality(5y)205.36%
High Growth Momentum
Growth
EPS 1Y (TTM)-5.99%
EPS 3Y13.76%
EPS 5Y15.23%
EPS Q2Q%-1.19%
EPS Next Y-5.37%
EPS Next 2Y-4.18%
EPS Next 3Y0.09%
EPS Next 5Y2.14%
Revenue 1Y (TTM)-2.46%
Revenue growth 3Y14.75%
Revenue growth 5Y24.17%
Sales Q2Q%0.63%
Revenue Next Year-2.67%
Revenue Next 2Y-1.68%
Revenue Next 3Y0.21%
Revenue Next 5Y1.48%
EBIT growth 1Y-0.88%
EBIT growth 3Y26.12%
EBIT growth 5Y22.99%
EBIT Next Year0.19%
EBIT Next 3Y0.21%
EBIT Next 5Y2.03%
FCF growth 1Y86.71%
FCF growth 3Y15.01%
FCF growth 5Y25.32%
OCF growth 1Y72.39%
OCF growth 3Y15.78%
OCF growth 5Y25.55%

ICON PLC / ICLR Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for ICON PLC?

ChartMill assigns a fundamental rating of 5 / 10 to ICLR.


What is the valuation status for ICLR stock?

ChartMill assigns a valuation rating of 7 / 10 to ICON PLC (ICLR). This can be considered as Undervalued.


What is the profitability of ICLR stock?

ICON PLC (ICLR) has a profitability rating of 6 / 10.


Can you provide the financial health for ICLR stock?

The financial health rating of ICON PLC (ICLR) is 4 / 10.